Finance

Beta
Lists
PVCT:OTCMKTS
Provectus Biopharmaceuticals Inc
$0.063
+0.13%
(+0.000080) 1D
Jun 8, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PVCT...
Open
$0.06
High
$0.06
Low
$0.06
Mkt. cap
27.84M
Avg. vol.
173.82K
Volume
17.00K
52-wk high
$0.10
52-wk low
$0.04
EPS
-$0.01
Beta
0.85
Shares outstanding
420.28M
No. of employees
6
Open
$0.06
High
$0.06
Low
$0.06
Mkt. cap
27.84M
Avg. vol.
173.82K
Volume
17.00K
52-wk high
$0.10
52-wk low
$0.04
EPS
-$0.01
Beta
0.85
Shares outstanding
420.28M
No. of employees
6
News stories
From sources across the web
About Provectus Biopharmaceuticals Inc
CEO-
Employees6
Founded2002
HeadquartersKnoxville, Tennessee, United States
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
57.48K
-
-
-
Cost of goods sold
858.90K
323.22K
248.94K
310.93K
Cost of revenue
858.90K
323.22K
248.94K
310.93K
Research and development expenses
-
13.64K
13.64K
13.34K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
874.18K
831.08K
761.24K
923.63K
Operating expense
874.18K
844.72K
774.88K
936.98K
Total operating expenses
1.73M
1.17M
1.02M
1.25M
Operating income
-1.68M
-1.17M
-1.02M
-1.25M
Other non operating income
-
-
-
-
EBT including unusual items
-1.85M
-1.32M
-1.17M
-1.30M
EBT excluding unusual items
-1.73M
-1.22M
-1.07M
-1.30M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.81M
-1.31M
-1.17M
-1.29M
Net profit margin
-3,156.61%
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-51.35K
-48.02K
-47.32K
-53.05K
Net interest expenses
-51.35K
-48.02K
-47.32K
-53.05K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.68M
-1.17M
-1.02M
-1.25M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more